Biodel Company Profile (NASDAQ:BIOD)

Analyst Ratings

Consensus Ratings for Biodel (NASDAQ:BIOD) (?)
Ratings Breakdown: 3 Hold Rating(s)
Consensus Rating:Hold (Score: 2.00)
Consensus Price Target: $2.00 (359.77% upside)

Analysts' Ratings History for Biodel (NASDAQ:BIOD)
Show:
DateFirmActionRatingPrice TargetActions
12/18/2015Ladenburg ThalmannDowngradeBuy -> NeutralView Rating Details  Tweet This Rating  Share This Rating on StockTwits
12/18/2015William BlairDowngradeOutperform -> Market PerformView Rating Details  Tweet This Rating  Share This Rating on StockTwits
10/14/2015WedbushReiterated RatingNeutral$2.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
5/18/2015Roth CapitalInitiated CoverageBuy$5.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
(Data available from 7/30/2014 forward)

Earnings

Earnings History for Biodel (NASDAQ:BIOD)
DateQuarterConsensus EstimateActual EPSRevenue EstimateActual RevenueRelease LinkConference CallActions
8/11/2016        
5/9/2016Q2($0.04)($0.09)ViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
2/16/2016Q1($0.08)($0.05)ViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
12/17/2015Q315($0.11)($0.05)ViewListenView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
8/13/2015Q3($0.10)($0.12)ViewListenView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
5/6/2015Q215($0.23)($0.18)ViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
2/12/2015Q115($0.17)($0.20)ViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
12/17/2014Q414($0.25)($0.16)ViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
8/11/2014($0.26)($0.15)ViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
5/13/2014Q114($0.24)($0.29)ViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
2/6/2014Q4($0.19)($0.20)ViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
12/18/2013Q4($0.32)($0.04)ViewListenView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
8/12/2013Q3 2013($0.37)($0.66)ViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
5/8/2013Q2 2013($0.43)($0.37)ViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
(Data available from 1/1/2011 forward)

Estimates

Earnings Estimates for Biodel (NASDAQ:BIOD)
QuarterNumber of EstimatesLow EstimateHigh EstimateAverage Estimate
Q4 20161($0.05)($0.05)($0.05)
Q1 20171($0.05)($0.05)($0.05)
Q2 20171($0.05)($0.05)($0.05)
Q3 20171($0.05)($0.05)($0.05)
(Data provided by Zacks Investment Research)

Dividends

Dividend History for Biodel (NASDAQ:BIOD)
No dividend announcements for this company have been tracked by MarketBeat.com

Insider Trades

Insider Trading History for Biodel (NASDAQ:BIOD)
Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionActions
12/20/2013Brian Jg PereiraDirectorSell4,734$2.26$10,698.84View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
(Data available from 1/1/2013 forward)

Headlines

Latest Headlines for Biodel (NASDAQ:BIOD)
DateHeadline
07/29/16 02:51 PMNoteworthy Buzzers: Community Health Systems, Inc. (NYSE:CYH) , Biodel Inc. (NASDAQ:BIOD) - Street Updates
07/29/16 02:51 PMBiodel Inc. (NASDAQ:BIOD) Insider Activities Are in the Air - Review Fortune
07/28/16 03:54 PMNoticeable Buzzers: Medtronic plc (NYSE:MDT) , Biodel Inc ... - Street Updates
07/26/16 02:45 PMStocks Movements Activity: Tobira Therapeutics, Inc. (NASDAQ:TBRA) , Biodel Inc. (NASDAQ:BIOD) - Street Updates
07/21/16 08:25 PMBiodel Inc. (NASDAQ:BIOD): Sell-Side Ratings and Company Earnings Glance - Engelwood Daily
07/20/16 10:53 AMEquity Roundup: Stock Performance Focus on Biodel Inc. (NASDAQ:BIOD) - Press Telegraph
07/19/16 09:01 AMHow Analysts Rated Biodel Inc (NASDAQ:BIOD) Last Week? - Press Telegraph
07/18/16 07:47 AMThomas A. Shea Joins Albireo as Chief Financial Officer
07/14/16 02:52 PMAnalyst Target and Average Rating Watch: Biodel Inc. (NASDAQ:BIOD) - Press Telegraph
07/14/16 02:52 PMBiodel Inc (NASDAQ:BIOD) Move Up as Institutional Investors' Sentiment Falls - Consumer Eagle
07/14/16 02:52 PMBiodel Inc. (NASDAQ:BIOD) Earnings Concentration and Analyst Target Watch - Engelwood Daily
07/13/16 10:55 AMBIODEL INC : Entry into a Material Definitive Agreement, Financial Statements and Exhibits (form 8-K)
07/12/16 04:19 AMBiodel Inc. (NASDAQ:BIOD) Wall Street Analyst Recommendation Outlook - Telanagana Press
07/10/16 07:33 AMHow Many Biodel Inc (NASDAQ:BIOD)'s Analysts Are Bearish? - Engelwood Daily
07/07/16 02:50 PMCan Biodel Inc. (NASDAQ:BIOD) Improve on the Earnings Front? - Engelwood Daily
07/07/16 10:46 AMCompany Stock Focus for Biodel Inc. (NASDAQ:BIOD): Which Way Will Shares Head? - Press Telegraph
07/06/16 07:39 AMBiodel Inc. (BIOD) Current Analyst Ratings - Fiscal Standard
07/04/16 02:46 PMBiodel Inc. (BIOD) Broker Price Targets For The Coming Week - Fiscal Standard
07/03/16 07:35 AMHow Many Biodel Inc (NASDAQ:BIOD)'s Analysts Are Bullish? - Press Telegraph
06/28/16 03:01 PMPen Needles Market Forecast to Grow at 11.2% CAGR to 2021 led by Standard Needles Segment
06/27/16 02:29 PMNew Broker Ratings For Biodel Inc. (BIOD) - FTSE News
06/23/16 10:17 PMBiodel Inc. (NASDAQ:BIOD) Earnings Glance and Target Price Review - Engelwood Daily
06/21/16 07:36 AMRecently Issued Stock Ratings For Biodel Inc. (BIOD) - Fiscal Standard
06/16/16 08:13 PMType 1 Diabetes Market : Size, Share, Development, Growth and Demand Forecast to 2015 – 2021
06/16/16 07:13 AMNotable Stocks within Investor Radar: Biodel Inc. (NASDAQ:BIOD) , Inovio Pharmaceuticals, Inc. (NASDAQ:INO) - Street Updates
06/15/16 02:53 PMHave a look at Price Moves: Depomed, Inc. (NASDAQ:DEPO) , Biodel Inc. (NASDAQ:BIOD) - Street Updates
06/03/16 08:55 PMStock Review and Earnings Check on Biodel Inc. (NASDAQ:BIOD) - HNN
06/03/16 02:55 PMEarnings Trends of the Stock: Biodel Inc. (NASDAQ:BIOD), OncoGenex Pharmaceuticals, Inc. (NASDAQ:OGXI) - Beacon Chronicle
06/03/16 11:25 AMBiotech Stocks within Traders Radar: Immunomedics, Inc. (NASDAQ:IMMU) , Biodel Inc. (NASDAQ:BIOD) - Is stories
06/01/16 11:20 AMTarget Price and Stock Performance Rundown for Biodel Inc. (NASDAQ:BIOD) - HNN - Target Price and Stock Performance Rundown for Biodel Inc. (NASDAQ:BIOD)HNNKeeping an eye on share activity using multiple views may be helpful when tracking stock performance. Equity investors have the ability to track short or long term share performance. During the latest trading session, Biodel Inc. (NASDAQ:BIOD) shares ...and more »
05/31/16 02:52 PMLatest Analysts Tips Update: Johnson & Johnson (NYSE:JNJ) , Biodel Inc. (NASDAQ:BIOD) - Street Updates - Latest Analysts Tips Update: Johnson & Johnson (NYSE:JNJ) , Biodel Inc. (NASDAQ:BIOD)Street UpdatesJohnson & Johnson (NYSE:JNJ) accumulated +0.14%, closing at $113.06 after floating between $112.69 and $113.34. The company has market capitalization of $310.99B. It has twelve month low of $81.79 and twelve month high of $115.00. The recent ...and more »
05/29/16 02:03 PMHow Analysts Feel About Biodel Inc (NASDAQ:BIOD)? - HNN - How Analysts Feel About Biodel Inc (NASDAQ:BIOD)?HNNOut of 1 analysts covering Biodel (NASDAQ:BIOD), 0 rate it a “Buy”, 0 “Sell”, while 1 “Hold”. This means 0% are positive. Biodel has been the topic of 2 analyst reports since December 18, 2015 according to StockzIntelligence Inc. Below is a list of ...Biodel Inc. (NASDAQ:BIOD) One-Year Price Target At $3.500Equities FocusBiodel Inc. (NASDAQ:BIOD) Quarterly EPS From Continuing Operations Stands At $-0.0915Investor Newswireall 3 news articles »
05/28/16 01:38 PMEarnings Review and Stock Rundown for Biodel Inc. (NASDAQ:BIOD) - Wall Street Hints and News - Earnings Review and Stock Rundown for Biodel Inc. (NASDAQ:BIOD)Wall Street Hints and NewsInvestors and analysts will be paying close attention when the company posts earnings results. Earnings numbers can provide insight into a company's overall profitability. Covering equity analysts are expecting Biodel Inc. (NASDAQ:BIOD) to post ...and more »
05/28/16 01:38 PMHC Stocks Updates: Ariad Pharmaceuticals, Inc. (NASDAQ:ARIA), Biodel Inc (NASDAQ:BIOD) - share market updates (press release) - share market updates (press release)HC Stocks Updates: Ariad Pharmaceuticals, Inc. (NASDAQ:ARIA), Biodel Inc (NASDAQ:BIOD)share market updates (press release)Shares of Ariad Pharmaceuticals, Inc. (NASDAQ:ARIA) ended Thursday session in red amid volatile trading. The shares closed down -0.12 points or -1.47% at $8.03 with 2.00 million shares getting traded. Post opening the session at $8.14, the shares hit ...
05/28/16 01:38 PMAnalyst Rating Trends to Observe: Pernix Therapeutics Holdings, Inc. (NASDAQ:PTX) , Biodel Inc. (NASDAQ:BIOD) - Street Updates - The Point ReviewAnalyst Rating Trends to Observe: Pernix Therapeutics Holdings, Inc. (NASDAQ:PTX) , Biodel Inc. (NASDAQ:BIOD)Street UpdatesBiodel Inc. (NASDAQ:BIOD) showed bearish move with loss of -20.217% after exchanging volume of 3.02 million shares in last trading session ended on 5/26/2016. The company recent traded volume was higher than its average volume of 1.21 million shares ...Drug-Makers on Vanguard Level- Biodel (NASDAQ:BIOD), Pernix Therapeutics (NASDAQ:PTX)Seneca Globeall 33 news articles »
05/28/16 01:38 PMBiotech Stock Picking: Biodel Inc (NASDAQ:BIOD) - The Point Review - The Point ReviewBiotech Stock Picking: Biodel Inc (NASDAQ:BIOD)The Point ReviewShare of Biodel Inc (NASDAQ:BIOD) traded on -9.47 percent below secure line at 2:33PM EDT in order to take the company's stock at the price of $0.325. At the time of writing the stock exchanged hands 1.84 million shares versus average trading capacity ...Biodel Inc. (NASDAQ:BIOD) Closes At $0.3670Markets DailyBroker Changes For Biodel Inc. (BIOD)Risers & FallersHealthcare Worth Watching Stocks : Biodel Inc (NASDAQ:BIOD), Bristol-Myers Squibb Co (NYSE:BMY)NYSE Journal (press release)Street Updates -CWRU Observerall 14 news articles »
05/26/16 01:42 PMStocks Moving Upward: Citigroup Inc (NYSE:C), Biodel Inc (NASDAQ:BIOD) - NYSE Journal (press release) - NYSE Journal (press release)Stocks Moving Upward: Citigroup Inc (NYSE:C), Biodel Inc (NASDAQ:BIOD)NYSE Journal (press release)Citigroup Inc (NYSE:C), belongs to Financial sector and Money Center Banks industry. C stock opened its current trade at $46.19 and now floating in a range of $46.19 to $47.60, trading at $46.89. C stock gain 2.24% in total of its share price. C stock ...and more »
05/26/16 01:42 PMHealthcare stocks to Observe: Biodel Inc. (NASDAQ:BIOD) , Inovio Pharmaceuticals, Inc. (NASDAQ:INO) - Is stories - Is storiesHealthcare stocks to Observe: Biodel Inc. (NASDAQ:BIOD) , Inovio Pharmaceuticals, Inc. (NASDAQ:INO)Is storiesBiodel Inc. (NASDAQ:BIOD) increased +21.05% to $0.46 while traded 9.49 million shares on 5/25/2016. The stock price negotiated for value between $0.42 to $0.53 in recent trading session. During the past 52 weeks, the stock's price witnessed a minimum ...and more »
05/26/16 07:08 AMBIODEL INC Files SEC form 8-K, Entry into a Material Definitive Agreement, Financial Statements and Exhibits -
05/25/16 12:58 PMBiodel Inc. (NASDAQ:BIOD) Closes At $0.3900 - Investor Newswire - Biodel Inc. (NASDAQ:BIOD) Closes At $0.3900Investor NewswireYesterday, the stock of Biodel Inc. (NASDAQ:BIOD) closed at $0.3900 after opening at $0.4000 and registering high of $0.4059 and low of $0.3812. The last price is $-0.7803 off 1-year high of $1.1800 and $0.1797 away from low of $0.2200 during same ...and more »
05/25/16 12:58 PMStocks Movements to Focus: Cerus Corporation (NASDAQ:CERS) , Biodel Inc. (NASDAQ:BIOD) - Street Updates - Stocks Movements to Focus: Cerus Corporation (NASDAQ:CERS) , Biodel Inc. (NASDAQ:BIOD)Street UpdatesOn 5/20/2016, Cerus Corporation (NASDAQ:CERS) ended trading session higher at $5.20 with +2.56%. The company traded a volume of 1.52 million shares as comparison to average volume of 1.22 million shares. During the 52 –week period, the stock's ...and more »
05/25/16 11:54 AMBIODEL INC Files SEC form 8-K, Other Events, Financial Statements and Exhibits -
05/25/16 08:38 AMBiodel/Albireo Limited to Combine; Focus on Liver Diseases -
05/25/16 01:52 AM2:52 am Biodel and Albireo agree to combine through share exchange agreement -
05/24/16 07:04 PMBiodel Inc. and Albireo Limited Agree to Combine - [Marketwired] - Biodel Inc. Transaction to result in NASDAQ-listed company focused in orphan pediatric liver diseases Albireo brings wholly owned, Phase 2 lead asset A4250 to treat Progressive Familial Intrahepatic......
05/24/16 01:22 PMAWS Morning Technical Breakdown Highlights: Novo Nordisk, Biodel, Sucampo Pharma, and SciClone Pharma - Additionally, Novo Nordisk’s stock has a Relative Strength Index (RSI) of 44.11. Shares of specialty biopharmaceutical company, Biodel Inc., ended the session at $0.39, gaining 1.59%. The stock recorded a trading volume of 1.05 million shares.
05/20/16 01:10 PMLatest Analyst Ratings For Biodel Inc. (BIOD) - Share Trading News - Latest Analyst Ratings For Biodel Inc. (BIOD)Share Trading News12/18/2015 – Biodel Inc. was downgraded to “market perform” by analysts at William Blair. 10/14/2015 – Biodel Inc. had its “neutral” rating reiterated by analysts at Wedbush. They now have a USD 2 price target on the stock. 05/18/2015 – Roth Capital ...
05/18/16 01:27 PMRevenue Update on Biodel Inc(NASDAQ:BIOD) - Trade Calls - Revenue Update on Biodel Inc(NASDAQ:BIOD)Trade CallsBiodel Inc(NASDAQ:BIOD) announced the earnings results for Fiscal Year 2016 and Q2. The results came in during After-hours on May 9, 2016. Earnings per share were $-0.09. Analysts had estimated an EPS of $-0.04. Biodel Inc (BIOD) shares turned ...
05/17/16 01:41 PMBiodel Inc. (NASDAQ:BIOD) Hovering Around $0.3975 - Investor Newswire - Biodel Inc. (NASDAQ:BIOD) Hovering Around $0.3975Investor NewswireOn performing technical analysis of Biodel Inc. (NASDAQ:BIOD) stock, it is noted that the stock is $0.0105 points away +2.7360% from its fifty-day MA of $0.3843. It is $0.0697 or +21.4227% away $0.3251, the 200-day MA (Moving Average) of stock. Also ...
03/02/16 04:49 PMBIODEL INC Files SEC form 8-K, Change in Directors or Principal Officers -

Social

About Biodel

Biodel logoBiodel Inc. is a specialty biopharmaceutical company. The Company focuses on the development and commercialization of treatments for diabetes. The Company is engaged in developing product candidates by applying its formulation technologies to existing drugs. The Company is engaged in developing room temperature stable glucagon presentations for use as a rescue treatment for diabetes patients experiencing severe hypoglycemia. It also develops insulin formulations for Type 1 and Type 2 diabetes patients. Its product pipeline includes RHI-based Ultra-Rapid-Acting Insulin, Analog-based Ultra-Rapid-Acting Insulin, Concentrated Ultra-Rapid-Acting Insulin and Glucagon. The Company's BIOD-531 is a Concentrated Ultra-Rapid-Acting Insulin and its insulin analog-based ultra-rapid-acting insulin product candidates include BIOD-123, BIOD-531, BIOD-238 and BIOD-250. It also conducts pre-clinical testing to develop liquid formulations of glucagon for hypoglycemic rescue and other indications.

Industry, Sector and Symbol:
  • Sector: Medical
  • Industry: Drug Manufacturers - Other
  • Sub-Industry: N/A
  • Exchange: NASDAQ
  • Symbol: BIOD
  • CUSIP:
Key Metrics:
  • Previous Close: $0.45
  • 50 Day Moving Average: $0.332
  • 200 Day Moving Average: $0.337
  • P/E Ratio: N/A
  • P/E Growth: 0.000
  • Market Cap: $27.90M
  • Beta: 1.91
  • Current Year EPS Consensus Estimate: $-0.17 EPS
Additional Links:
Biodel (NASDAQ:BIOD) Chart for Saturday, July, 30, 2016